Brief: Propanc Biopharma Announces Nasdaq Uplisting And Pricing Of $4 Million Public Offering
15/08/2025 04:01
Aug 14 (Reuters) - Propanc Biopharma Inc PPCB.PK: PROPANC BIOPHARMA ANNOUNCES NASDAQ UPLISTING AND PRICING OF $4 MILLION PUBLIC OFFERING PROPANC BIOPHARMA INC - PRICES PUBLIC OFFERING OF 1,000,000 SHARES AT $4.00 EACH Source text: ID:nGNX72y6Sg Further company coverage: PPCB.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Propanc Biopharma
See all newsNASDAQ TRADE HALT HALT NEWS PENDING AT 09:29 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition With Prp In Pancreatic Cancer Models, Contrasting Profile With Revolution Medicines’ Daraxonrasib
Brief: Propanc Biopharma Registers Resale Of 6,500,000 Shares Of Common Stock - SEC Filing
Brief: Propanc Biopharma To File Cta In Australia For Phase 1B Study In 30–40 Advanced Cancer Patients